Company
Qbtech
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
1
510(k), De Novo and PMA
Device trials
3
As lead sponsor, any status
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
Recall records
0
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Qbtech, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Qbtech.
Latest FDA decisions
- QbCheck510(k)
K143468 · Decided Mar 22, 2016 · 474 days after receipt
Device type: Recorder, Attention Task Performance (LQD) · Neurology & Neurosurgery
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT07329673 · 300 participants (planned) · Start Jan 1, 2026 · Primary completion Nov 2027
Device: Digital software application for cognitive performance and activity measurement (QbMobile, investigational device) · For: Bi-Polar Disorder; Autism Spectrum Disorder (ASD); Major Depression Disorders and 3 more
Sites: Miami, Florida
- An Investigational Study Examining the Cross-Validation of QbMobile in ADHD and Normative PopulationsEnrolling by invitation
NCT07220330 · 700 participants (planned) · Start Jan 15, 2025 · Primary completion Oct 2026
Device: QbMobile · For: No History of ADHD; Attention Deficit Hyperactivity Disorder (ADHD); Healthy Volunteer
Sites: San Jose, California; Largo, Florida; Orlando, Florida
- Augmenting Existing Normative Data for QbMobile in Healthy Children Aged 6-11 YearsNot yet recruiting
NCT07330960 · 150 participants (planned) · Start Jan 2026 · Primary completion Jan 2027
Device: Digital software application for cognitive performance and activity measurement (QbMobile, investigational device) · For: Healthy Volunteer
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
No reports to chart for this view.
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
No device types to rank.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
No brand names to rank.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recalls under this name in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.